References
- Early Breast Cancer Trialists' collaborative group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. The Lancet 1992; 339: 1–15, 71–85
- Walter P., Green S., Greene G. L., Krust A., Bornert J. M., Jeltsch J. M., Staub A., Jensen E., Scrace G., Waterfield M., Chambon P. Cloning of the human estrogen cDNA. Proc. Natl. Acad. Sci. USA 1985; 82: 7889–7893
- Sutherland R. L., Murphy L. C., Foo M. S., Green M. D., Whybourne A. M. High affinity anti-estrogen binding site distinct from the estrogen receptor. Nature 1980; 288: 273–275
- Fargin A., Faye J.-Ch., Le Maire M., Bayard F., Potier M., Beauregard G. Solubilization of a tamoxifen-binding protein. Biochem. J. 1988; 256: 229–236
- Chailleux C., Poirot M., Mesange F., Bayard F., Faye J.-Ch. Characterization of the membranous antiestrogen binding protein. J. Recept. Res.
- Poirot M., Chailleux C., Fargin A., Bayard F., Faye J.-Ch. A potent and selective photoaffinity probe for the antiestrogen binding site of rat liver. J. Biol. Chem. 1990; 265: 17039–17043
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Fargin A., Raymond J. R., Lohse M. J., Kobilka B. K., Caron M. G., Lefkowitz R. J. Nature 1988; 335: 358–360
- Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal α–oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992; 68: 879–887
- Kobilka B. K., Matsui H., Kobilka T. S., Yang-Feng T. L., Francke U., Caron M. G., Lefkowitz R. J., Regan J. W. Cloning, sequencing and expression gene coding for the human platelet α-adrenergic receptor. Science 1987; 238: 650–656